Horizon Tech Finance Provides $50M Loan Facility to Pelthos Therapeutics for ZELSUVMI and Xepi Cream Development

jueves, 15 de enero de 2026, 4:15 pm ET1 min de lectura
PTHS--

Horizon Technology Finance has provided a $50 million venture loan facility to Pelthos Therapeutics, with an initial funding of $30 million and up to $20 million for future growth. The loan proceeds will be used for working capital and general growth purposes. The facility will support Pelthos' continued growth, including promoting its treatments for molluscum contagiosum, impetigo, and head lice.

Horizon Tech Finance Provides $50M Loan Facility to Pelthos Therapeutics for ZELSUVMI and Xepi Cream Development

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios